Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion ...

The Globus family of brands has become a Sapphire-level partner to ASTA, marking the supplier's largest investment in the ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style ...

Globus Spirits recorded a revenue of Rs 8741.1 crore, up 18.3 per cent, as compared to Rs 739 crore a year ago.

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...

Welcome to Globus Medical's third quarter 2024 earnings call. At this time, all lines will be on mute and a Q&A session will ...

Globus Medical, Inc.'s ( NYSE:GMED ) recent soft profit numbers didn't appear to worry shareholders, as the stock ...

Shares of Globus Spirits extended its loss to second consecutive day, down over 16 percent to Rs 890 per share on November 13 ...

Amalgamated Bank trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.4% in the third quarter, ...

The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major ...

Shares of Globus Spirits Ltd declined 11% on November 12 as the spirits firm reported 88% drop in standalone net profit at Rs ...